COVID-19

Thrombin generation as a predictor of outcomes in patients with intracerebral hemorrhage 2:03
Thrombin generation as a predictor of outcomes in patients with intracerebral hemorrhage
Zsuzsa Bagoly • 29 Mar 2023
COVID-19 and the risk of demyelinating diseases 1:42
COVID-19 and the risk of demyelinating diseases
Lorna Galleguillos • 16 Feb 2023
SARS-CoV-2 infections may increase MS risk and risk of exacerbations 4:02
SARS-CoV-2 infections may increase MS risk and risk of exacerbations
Scott Montgomery • 14 Feb 2023
Underlying mechanisms of brain fog 7:31
Underlying mechanisms of brain fog
Sabina Brennan • 28 Oct 2022
T-cell response following COVID-19 vaccination in MS patients under treatment 1:48
T-cell response following COVID-19 vaccination in MS patients under treatment
João José Cerqueira • 28 Oct 2022
Impact of COVID-19 on the epidemiology of functional movement disorders 1:49
Impact of COVID-19 on the epidemiology of functional movement disorders
Alberto Espay • 16 Sep 2022
Follow-up studies of long COVID in patients with Parkinson’s disease 1:48
Follow-up studies of long COVID in patients with Parkinson’s disease
Susanne Schneider • 19 Sep 2022
Evaluating the impact of COVID-19 on patients with movement disorders 2:26
Evaluating the impact of COVID-19 on patients with movement disorders
Susanne Schneider • 21 Sep 2022
COVID-19 and movement disorders 3:54
COVID-19 and movement disorders
Susanne Schneider • 21 Sep 2022
Evaluating the feasibility of telemedicine in movement disorders care 1:56
Evaluating the feasibility of telemedicine in movement disorders care
Esther Cubo • 15 Sep 2022
COVID-19 and post-acute neurological sequelae 4:12
COVID-19 and post-acute neurological sequelae
Jennifer Frontera • 3 Apr 2022
Updates on peripheral autoimmune neurological conditions 2:44
Updates on peripheral autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Efforts to expedite progress in neurology after the COVID-19 pandemic 1:11
Efforts to expedite progress in neurology after the COVID-19 pandemic
Nina Schor • 4 Apr 2022
Evaluating the long-term cognitive effects of COVID-19 3:56
Evaluating the long-term cognitive effects of COVID-19
Jennifer Frontera • 3 Apr 2022
Prognostic and predictive biomarkers for long COVID 2:26
Prognostic and predictive biomarkers for long COVID
Jennifer Frontera • 3 Apr 2022
Benefits of remote rehabilitation programmes for patients with MS 1:51
Benefits of remote rehabilitation programmes for patients with MS
Letizia Leocani • 4 Apr 2022
The content of VJNeurology is intended for healthcare professionals